Alexander Mosley Charitable Trust

The Alexander Mosley Charitable Trust (AMCT), founded in 2011 by Max Mosley to honor his son Alexander who died in 2009, is a proactive grant-maker dedicated to funding innovative, transformative projects in underserved or controversial areas overlooked by mainstream funders. Guided by trustees' discretion, its mission emphasizes public benefit through bold, evidence-based interventions in scientific research, mental health, road safety, environmental protection, justice, youth wellbeing, and independent media amplifying underrepresented voices. Distinctive for its risk-tolerant approach, AMCT backs pioneering work like Imperial College's psilocybin depression trials and large endowments to Oxford University (£6m Biophysics Professorship) and colleges for disadvantaged students.

It prioritizes national UK charities and academic institutions with significant impact, supporting mental health via Brook and the Brent Centre, environmental efforts through River Action and wildlife trusts, media independence with IMPRESS, and regenerative agriculture. Beneficiaries are strategically selected for their capacity to deliver lasting change, often via project, core, or capital grants.

Eligible entities are UK-registered charities or academic institutions based in the UK (primarily England and Wales), with a preference for medium-to-large organizations of national profile; unsolicited applications are not accepted—invitations only. Typical grants range from £500,000 to £6m, designed for transformational impact, with ad hoc trustee meetings and no fixed deadlines.

AMCT stands out for its aversion to racism and extremism, robust governance, and willingness to fund unconventional, high-stakes initiatives others avoid, ensuring strategic, multi-year support for breakthrough social and scientific progress.